Rheos Medicines

Rheos Medicines is a biopharmaceutical company developing novel drugs that modulate immune cell metabolic pathways to treat diseases. Their approach targets the underlying cellular metabolism of immune cells to alter the fate and function of specific cell types for treating immune-mediated diseases. By simultaneously identifying new drug targets and characterizing disease biomarkers, they are bringing precision to the treatment of immune-mediated diseases.